Name | Silverstone Place |
---|---|
Location | 2735 Eagleson Dr, Rolla, Missouri |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 110 |
Occupancy Rate | 59.91% |
Medicare ID (CCN) | 265851 |
Legal Business Name | Silverstone Snf Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1003224825 |
Organization Name | SILVERSTONE SNF LLC |
Address | 2735 Eagleson Dr, Rolla, MO 65401 |
Phone Number | 573-426-6200 |
News Archive
STERIPLEX® Health Care (HC) is a new Sterilant/Sporicide, Tuberculocide, and Bactericide, which has recently received Federal EPA Registration. STERIPLEX® HC sets new standards, killing MRSA, spores and other pathogens in a fraction of the time of competing products while remaining safe to people and the environment.
Researchers say that stubbornly low rates of beta-blocker prescribing in patients with chronic obstructive pulmonary disease could be contributing toward increased mortality in these patients following myocardial infarction.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new "first response" mechanism that the immune system uses to respond to infection. The findings challenge the current understanding of immunity and could lead to new strategies for boosting effectiveness of all vaccines. The study, conducted in mice, published online today in the journal Immunity.
MAP Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application to the United States Food and Drug Administration for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
STERIPLEX® Health Care (HC) is a new Sterilant/Sporicide, Tuberculocide, and Bactericide, which has recently received Federal EPA Registration. STERIPLEX® HC sets new standards, killing MRSA, spores and other pathogens in a fraction of the time of competing products while remaining safe to people and the environment.
Researchers say that stubbornly low rates of beta-blocker prescribing in patients with chronic obstructive pulmonary disease could be contributing toward increased mortality in these patients following myocardial infarction.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new "first response" mechanism that the immune system uses to respond to infection. The findings challenge the current understanding of immunity and could lead to new strategies for boosting effectiveness of all vaccines. The study, conducted in mice, published online today in the journal Immunity.
MAP Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application to the United States Food and Drug Administration for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 1 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.86 | 14.46 |
Percentage of long-stay residents who lose too much weight | 0.39 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.8 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.73 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 19.58 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.26 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.25 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.21 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 7.27 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 23.47 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.76 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 15.44 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.14 | 95.98 |
Percentage of short-stay residents who made improvements in function | 41.88 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.55 | 82.93 |
News Archive
STERIPLEX® Health Care (HC) is a new Sterilant/Sporicide, Tuberculocide, and Bactericide, which has recently received Federal EPA Registration. STERIPLEX® HC sets new standards, killing MRSA, spores and other pathogens in a fraction of the time of competing products while remaining safe to people and the environment.
Researchers say that stubbornly low rates of beta-blocker prescribing in patients with chronic obstructive pulmonary disease could be contributing toward increased mortality in these patients following myocardial infarction.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new "first response" mechanism that the immune system uses to respond to infection. The findings challenge the current understanding of immunity and could lead to new strategies for boosting effectiveness of all vaccines. The study, conducted in mice, published online today in the journal Immunity.
MAP Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application to the United States Food and Drug Administration for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
› Verified 6 days ago
Rolla Health & Rehabilitation Suites Location: 1200 Mccutchen Road, Rolla, Missouri 65401 Phone: (573) 364-2311 | |